July 29, 2025
NV Therapeutics signs Sponsored Research Agreement with UCLA

Agreement allows NV Therapeutics, Inc. to formalize collaborative research projects with the laboratory of Dr. Donald Kohn, Physician and Distinguished Professor of Pediatric Hematology and Oncology at the Broad Stem Cell Research Center, University of California, Los Angeles.

October 7, 2024
NV Therapeutics begins operations at Bakar Bio Labs incubator

NV Therapeutics, Inc. has established laboratory operations at Bakar Bio Labs, a world-class incubator site for life science startups in Berkeley, California. Founded as a partnership between University of California, Berkeley and QB3, the incubator provides a supportive ecosystem for NV Therapeutics to develop their platform technology and therapeutic programs.

September 13, 2024
NV Therapeutics secures Seed Funding from 4BIO Capital

Seed Funding from 4BIO Capital (4BIO Partners LLP), a London, United Kingdom based venture capital firm specializing in early-stage life sciences and advanced therapies, enables NV Therapeutics, Inc. to establish business operations and execute its recruitment and facility build plan.